Detection of gram-negative bacteraemia in early sepsis by a quantitative chromogenic and kinetic endotoxin assay

European Journal of Clinical Investigation

Volumn 26, Issue 7, 1996, Pages 596-601

  Massignon, D ^a   Lepape, A ^a   Debize, G ^a   Remillieux, M F ^a   De Pasquale, V ^a   Banssillon, V ^a   Coeur P ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Anti endotoxin therapy; endotoxaemia; limulus test

Indexed keywords

CHROMOGENIC SUBSTRATE; ENDOTOXIN;

ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; CHEMICAL REACTION KINETICS; ENDOTOXEMIA; GRAM NEGATIVE SEPSIS; HUMAN; LIMULUS LYSATE TEST; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0029746236     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.1810531.x     Document Type: Article

References (26)

1. Johnston J. Molecular science sets it sights on septic shock. J Natl Inst Health Res 1992;3:61-5.
2. Ziegler EJ, Fischer CJ, Sprung CL et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomised, double-blind, placebo-controlled trial. N Engl J Med 1991;324:111-19.
3. Greenman RL, Schein RMH, Martin MA et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1991;266: 1097-102.
4. Fisher CJ, Opal SM, Scott R, Marra M, Palardy JE. Bactericidal permeability increasing protein as a novel anti-endotoxin treatment modality in septic shock. Crit Care Med 1994;22: 553-8.
5. Kloczewiack M, Black KM, Loiselle P, Cavaillon JM, Wainwright N, Warren HS. Synthetic peptides that mimic the binding site of Horseshoe Crab Antilipopolysaccharide Factor. J Inf Dis 1994;170:1490-7.
6. Van Deventer SJH, Büller HR, Ten Cate JW, Sturk A, Pauw W. Endotoxemia: an early predictor of septicaemia in febrile patients. Lancet 1988;1:605-9.
7. Parsons PE, Worthen GS, Moore EE, Tate RM, Henson PM. The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am Rev Respir Dis 1989;140:294-301.
8. Van Deventer SJH, De Vreis I, Statius Van Eps LW et al. Endotoxemia, bacteremia and urosepsis. In: Levin J, Büller HR, Ten Cate JW, Van Deventer SJH, Sturk A, eds. Bacterial endotoxin. Pathophysiological Effects, Clinical Significance and Pharmacological Control. New York: Alan R Liss, 1988; 213-24.
9. Brandtzaeg P, Kierulf P, Gaustad P et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989;159:195-204.
10. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE. Endotoxemia in human septic shock. Chest 1991;99: 169-75.
11. Roth RI, Levin FC, Levin J. Optimization of detection of bacterial endotoxin in plasma with the Limulus test. J Lab Clin Med 1990;116:153-61.
12. Bone CR, Balk RA, Cerra FB et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;6:1644-55.
13. Van Deventer SJH, Büller HR, Sturk A, Ten Cate JW. Predicting septicemia with assays for bacterial LPS (endotoxin). In: Baumgartner JD, Calandra T, Carlet J, eds. Endotoxin from Pathophysiology to Therapeutic Approaches (Maurice Rapin colloquia), Flammarion, 1990:43-57.
14. Ravin HA, Rowley D, Jenkins C, Fine J. On the absorption of bacterial endotoxin from the gastrointestinal tract of the normal and shocked animal. J Exp Med 1960;112:783-92.
15. Stumacher RJ, Kovnat MJ, McCabe WR. Limitations of the usefulness of the limulus assay for endotoxin. N Engl J Med 1973;283:1261-4.
16. Elin RJ, Robinson RA, Levine AS, Wolff SM. Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N Engl J Med 1975;293:521-4.
17. Obayashi T, Tamura H, Shigenori T et al. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985;149: 55-65.
18. Herring WB, Herion JC, Walker RI, Palmer JG. Distribution and clearance of circulating endotoxin. J Clin Invest 1963;43: 79-87.
19. Griesman SE, Hornick RB, Wagner H, Woodward WE, Woodward TE. The role of endotoxin during typhoid fever and tularemia in man. IV. The role of the endotoxin tolerance mechanism during infection. J Clin Invest 1969;48:613-29.
20. Suffredini AF, Fromm RE, Parker MM et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321:280-7.
21. Van Deventer SJH, Büller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990;76:2520-6.
22. Guidet B, Barakett V, Vassal T, Petit JC, Offenstadt G. Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 1994;106:1194-201.
23. Danner RL, Natanson C, Elin RJ et al. P. aeruginosa compared to E. coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest 1990;98:1480-7.
24. Van Noordwijk J. Parallel line assays of endotoxins with the LAL chromogenic substrat method. In: Ten Cate JW, Büller HR, Sturk A, Levin J, eds. Bacterial endotoxins. Structure, Biomedical Significance, and Detection with the Limulus amoebocyte lysate test. New York: Alan R. Liss, 1985;69-80.
25. Van Noordwijk J, Hillen FC, Hagelen F. The relative activity of endotoxins of different origins in the LAL gelation method and the LAL chromogenic substrate method. In: Watson SW, Levi J, Novitsky RJ, eds. Detection of Bacterial Endotoxins with the Limulus Amoebocyte Lysate Test. New York: Alan R. Liss, 1987;103-13.
26. Brandtzaeg P, Sandset PM, Joo GB, Ovstebe R, Abildgaard U, Kierulf P. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989;55:459-70.